The application of albumin-based MnO2 NPs showed clinical relevance by modulating tumor hypoxia and enhancing radiotherapy efficacy in xenograft tumor models of murine and human breast cancers (Prasad et al., 2014; Abbasi et al., 2016; Tian et al., 2017). This evidence concerns the gene ALB and neoplasm.